Michel Lagarde - 04 Dec 2025 Form 4 Insider Report for THERMO FISHER SCIENTIFIC INC. (TMO)

Reporting relationship: Executive Vice President & COO
Issuer ticker: TMO
Reported as of: 04 Dec 2025
Net transaction value: -$7,539,568
SEC form: 4
Accepted by SEC: 05 Dec 2025, 16:40:22 UTC
Prior SEC filing: 04 Dec 2025
Next SEC filing: 27 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Melodie T. Morin, Attorney-in-Fact for Michel Lagarde

Key filing fact

Michel Lagarde filed Form 4 for THERMO FISHER SCIENTIFIC INC. (TMO) on 05 Dec 2025.

Key facts

This page summarizes Michel Lagarde's Form 4 filing for THERMO FISHER SCIENTIFIC INC. (TMO).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 05 Dec 2025, 16:40.

Change

Previous filing in this sequence was filed on 04 Dec 2025.
Current net transaction value: -$7,539,568.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001518973 Primary reporting owner

Lagarde Michel

Relationship: Executive Vice President & COO
Address: 168 THIRD AVENUE, WALTHAM
Signature: /s/ Melodie T. Morin, Attorney-in-Fact for Michel Lagarde
Signature date: 05 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TMO transaction

Common Stock

Options Exercise

Transaction value: $1,960,053
Shares: +18,637
Change %: +28%
Price: $105.17
Shares after: 84,117
Date: 04 Dec 2025
Ownership: Direct

TMO transaction

Common Stock

Options Exercise

Transaction value: $2,924,622
Shares: +22,046
Change %: +26%
Price: $132.66
Shares after: 106,163
Date: 04 Dec 2025
Ownership: Direct

TMO transaction

Common Stock

Sale

Transaction value: $12,424,244
Shares: -22,046
Change %: -21%
Price: $563.56
Shares after: 84,117
Date: 04 Dec 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TMO transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -22,046
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 04 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 22,046
Exercise price: $132.66
Footnotes: F2

TMO transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -18,637
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 04 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 18,637
Exercise price: $105.17
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $563.38 to $564.20, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F2

The option vested in three equal installments on March 23, 2018, 2019 and 2020.

Footnote F3

The option vested in two equal installments on August 29, 2017 and 2020.